金邦達寶嘉(03315.HK)去年盈利按年跌17.7% 派末期及特息共14港仙
金邦達寶嘉(03315.HK)截至去年12月底止年度業績公告顯示,集團錄得淨利潤約1.45億元人民幣(下同),按年下降約17.7%。若剔除匯兌損失產生的賬面損失,淨利潤將按年上升約5.6%。基本每股盈利17.6分。公司擬派發末期股息每股10港仙及派特別息4港仙,上年同期派發末期股息每股10港仙及派特別息6港仙。
期內,受新型冠狀病毒疫情及行業競爭的影響,錄得收入按年跌9.4%至約12.8億元。毛利按年跌3.7%至3.84億元。得益於精細化管理方面的有效措施,毛利率按年升約1.7個百分點至約29.9%。(ta/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.